Literature DB >> 24015729

Morphology of far-field electrograms and antitachycardia pacing effectiveness among fast ventricular tachycardias occurring in ICD patients: a multicenter study.

Javier Jiménez-Candil1, Ignasi Anguera, Claudio Ledesma, Javier Fernández-Portales, José Luis Moríñigo, Paolo Dallaglio, Ana Martín, Teresa Cano, Jesús Hernández, Xavier Sabaté, Cándido Martín-Luengo.   

Abstract

INTRODUCTION: Fast ventricular tachycardias (FVT) are less likely to be terminated by antitachycardia pacing (ATP). No information is available regarding the ability of far-field electrogram (Ff-EG) morphology (Ff-EGm) in predicting the result of the subsequent ATP. Our objective is to determine the relationship between Ff-EGm and ATP efficacy. METHODS AND
RESULTS: In this multicenter study we analyzed 289 FVT (cycle length [CL]: 250-320 milliseconds) occurring consecutively in 52 ICD patients with Medtronic devices (LVEF: 37 ± 6; pacing site: right ventricular apex). FVT programming was standardized, including a single ATP burst as initial therapy. The configuration of Ff-EG was HVA versus HVB. FVTs were classified in QFVT or non-QFVT according to the presence or absence of a negative initial deflection in the Ff-EG. The mean CL was 291 ± 24 milliseconds. We observed 4 Ff-EGm: QS (n = 14, 5%), QR (n = 158, 55%), R (n = 93, 32%), and RS (n = 24, 8%). The ATP effectiveness was 80% (86% in QS, 85% in QR, 74% in R, 62% in RS). The frequency of successful ATP was higher in QFVT: 86 versus 71% (P = 0.002). By logistic regression analysis, a QFVT pattern (OR = 2.3; P = 0.015) remained as an independent predictor of effective ATP. ATP was safer in QFVTs, the frequencies of shock (14% vs 29%; P = 0.002), acceleration (5.1 vs 12.3%; P = 0.02), and syncope (4.6 vs 12.3%; P = 0.01) being lower.
CONCLUSIONS: Since ATP is less effective in non-QFVTs, they are less well tolerated. Therefore, the substrate of non-QFVTs may need a specific treatment.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  antitachycardia pacing; heart failure; implantable cardiac defibrillator; sudden death; ventricular tachycardia

Mesh:

Year:  2013        PMID: 24015729     DOI: 10.1111/jce.12228

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  4 in total

Review 1.  Basic Properties And Clinical Applications Of The Intracardiac.

Authors:  Francesco Zanon; Lina Marcantoni; Gianni Pastore; Enrico Baracca; Silvio Aggio; Franco Di Gregorio; Alberto Barbetta; Mauro Carraro; Claudio Picariello; Luca Conte; Loris Roncon
Journal:  J Atr Fibrillation       Date:  2016-12-31

2.  Beta-blocker therapy is associated with a lower incidence of syncope due to fast ventricular tachycardias among implantable cardioverter-defibrillator patients with left ventricular dysfunction: results from a multicenter study.

Authors:  Javier Jiménez-Candil; Ignasi Anguera; Olga Durán; Jesús Hernández; Javier Fernández-Portales; José Luis Moríñigo; Ana Martín; Paolo Dallaglio; Loreto Bravo; Andrea di Marco; Pedro Luis Sánchez
Journal:  J Interv Card Electrophysiol       Date:  2018-03-20       Impact factor: 1.900

3.  Differences in ventricular tachyarrythmias and antitachycardia pacing effectiveness according to the ICD indication (primary versus secondary prevention): an analysis based on the stored electrograms.

Authors:  Javier Jiménez-Candil; Jesús Hernández; Ana Martín; José Moríñigo; Pedro Perdiguero; Loreto Bravo; Sonia Ruiz; Pedro L Sánchez
Journal:  J Interv Card Electrophysiol       Date:  2015-08-26       Impact factor: 1.900

4.  Electrical And Hemodynamic Evalution Of Ventricular And Supraventricular Tachycardias With An Implantable Dual-Chamber Pacemaker.

Authors:  Claudio Pandozi; Franco Di Gregorio; Carlo Lavalle; Renato Pietro Ricci; Sabina Ficili; Marco Galeazzi; Maurizio Russo; Angela Pandozi; Furio Colivicchi; Massimo Santini
Journal:  J Atr Fibrillation       Date:  2014-06-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.